B
Biohaven Ltd D
D
BHVN
14.580
USD
-0.17
(-1.15%)
مغلق
حجم التداول
19,257
الربح لكل سهم
-7
العائد الربحي
-
P/E
-2
حجم السوق
1,488,800,600
الأخبار المقالات
العنوان: Biohaven Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.